Prosecution Insights
Prosecution Insights
42 pending office actions • 24 art units • 40 examiners • 0 of 42 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 5 (12%) |
| §103 only | 11 (26%) |
| §102 only | 2 (5%) |
| §112 only | 6 (14%) |
| Double-patenting + other | 7 (17%) |
| Multi-statute (no §101) | 10 (24%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CELESTINE, NYROBI I | 2 | 81.4% | +23.1% |
| IVICH, FERNANDO NMN | 2 | 45.7% | +72.7% |
| WEBSTER, KARMEL JOHANNA | 1 | 66.7% | +23.3% |
| WILLIAMS, KEITH RICHARD | 1 | 41.7% | +0.0% |
| PIPIC, ALMA | 1 | 54.4% | +55.0% |
| BOLDEN, ELIZABETH A | 1 | 85.1% | +22.3% |
| LEE, CLAY C | 1 | 54.9% | +58.5% |
| AKAR, SERKAN | 1 | 65.7% | +33.4% |
| MURESAN, ANA Z | 1 | 74.9% | +31.7% |
| GUSTILO, ESTELLA M | 1 | 54.0% | +35.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18048873 | SYSTEM AND METHOD FOR ULTRASOUND ANALYSIS | CELESTINE, NYROBI I | 2d overdue |
| 18668340 | ELECTROSTRICTIVE MATERIALS BASED ON DOPED CERIA | BOLDEN, ELIZABETH A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18224345 | NON-PROTEIN PHENYLALANINE ANALOGUES FOR INHIBITING CYANOBACTERIA AND PLANT GROWTH | LIU, SUE XU | 168d overdue |
| 17614563 | ARTIFICIAL RECEPTORS, RECOMBINANT CELLS COMPRISING THEREOF, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF | IVICH, FERNANDO NMN | 168d overdue |
| 18106903 | TREATMENT OF AN ISCHEMIC HEART DISEASE | TAYLOR, LIA ELAN | 121d overdue |
| 18281341 | ACYL ACTIVATING ENZYME AND A TRANSGENIC CELL, TISSUE, AND ORGANISM COMPRISING SAME | SPEED, DEQUANTARIUS JAVON | 117d overdue |
| 15516407 | LIPOSOMES-CONTAINING ANTIFOULING COMPOSITIONS AND USES THEREOF | WESTERBERG, NISSA M | 87d overdue |
| 18701580 | SYSTEM FOR DETECTING AND/OR ASSESSING A SUBDURAL HEMATOMA | AKAR, SERKAN | 10d overdue |
| 18557941 | Biomarkers for Neurodegenerative Disease | COUNTS, GARY W | 13d |
| 17958516 | METHODS OF DIAGNOSING CANCER AND PREDICTING RESPONSIVENESS TO THERAPY | SWITZER, JULIET CAROLINE | 72d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17614563 | ARTIFICIAL RECEPTORS, RECOMBINANT CELLS COMPRISING THEREOF, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF | IVICH, FERNANDO NMN | 168d overdue |
| 17637098 | SCALED-UP METHODS FOR PURIFYING ANTIBODIES | IVICH, FERNANDO NMN | 44d overdue |
| 18701580 | SYSTEM FOR DETECTING AND/OR ASSESSING A SUBDURAL HEMATOMA | AKAR, SERKAN | 10d overdue |
| 18048873 | SYSTEM AND METHOD FOR ULTRASOUND ANALYSIS | CELESTINE, NYROBI I | 2d overdue |
| 19001657 | SYSTEM AND METHOD FOR DETECTING A CARDIAC ANOMALY | CELESTINE, NYROBI I | — |
| 18859560 | DIAGNOSING AND TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER | WEBSTER, KARMEL JOHANNA | — |
| 18792590 | DRUG-LOADED LIPOSOMES AND USES THEREOF IN TREATING BIOFILM | PIPIC, ALMA | — |
| 18668340 | ELECTROSTRICTIVE MATERIALS BASED ON DOPED CERIA | BOLDEN, ELIZABETH A | — |
| Art Unit | Apps |
|---|---|
| 1678 | 3 |
| 3798 | 2 |
| 1663 | 2 |
| 1641 | 2 |
| 1653 | 2 |
| 1794 | 2 |
| 1645 | 2 |
| 1644 | 2 |
| 1656 | 2 |
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19001657 | SYSTEM AND METHOD FOR DETECTING A CARDIAC ANOMALY | CELESTINE, NYROBI I | 3798 | §101§102§103Other | Non-Final OA | — | Pending | Dec 26, 2024 |
| 18859560 | DIAGNOSING AND TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER | WEBSTER, KARMEL JOHANNA | — | §101§102§103 | Non-Final OA | — | Pending | Oct 24, 2024 |
| 18845798 | TRANSGENIC HELICHRYSUM UMBRACULIGERUM CELL, TISSUE, OR PLANT | WILLIAMS, KEITH RICHARD | 1663 | §103§112 | Non-Final OA | — | Pending | Sep 10, 2024 |
| 18792590 | DRUG-LOADED LIPOSOMES AND USES THEREOF IN TREATING BIOFILM | PIPIC, ALMA | 1617 | §103§112 | Non-Final OA | — | Pending | Aug 02, 2024 |
| 18668340 | ELECTROSTRICTIVE MATERIALS BASED ON DOPED CERIA | BOLDEN, ELIZABETH A | — | §103 | Non-Final OA | — | Pending | May 20, 2024 |
| 18704571 | Robust multi-qubit gates for quantum computing | LEE, CLAY C | — | §103 | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18701580 | SYSTEM FOR DETECTING AND/OR ASSESSING A SUBDURAL HEMATOMA | AKAR, SERKAN | 3797 | §102§103§112 | Non-Final OA | 10d overdue | Pending | Apr 15, 2024 |
| 18692847 | PROCESS FOR THE PREPARATION OF THE SALBUTAMOL INTERMEDIATE | MURESAN, ANA Z | — | §103 | Non-Final OA | — | Pending | Mar 18, 2024 |
| 18692039 | MULTISPECIFIC ANTIBODIES FOR USE IN TREATING DISEASES | GUSTILO, ESTELLA M | — | §102§103§112DPOther | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18106903 | TREATMENT OF AN ISCHEMIC HEART DISEASE | TAYLOR, LIA ELAN | 1641 | §103§112Other | Final Rejection | 121d overdue | Pending | Mar 08, 2024 |
| 18408385 | T-CELLS COMPRISING ANTI-CD38 AND ANTI-CD138 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | BUNNER, BRIDGET E | — | §112DP | Non-Final OA | — | Pending | Jan 09, 2024 |
| 18572972 | INHIBITORS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE (PIN1), COMBINATIONS AND USES THEREOF | CESARE, JOSEPH DAVID | — | §102§112DP | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18530406 | COMBINED TREATMENT FOR CANCER | KARUNASENA, ENUSHA | 1653 | §101§103§112 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18559576 | PROCESS FOR THE PREPARATION OF ALUMINUM SCANDIUM NITRIDE FILMS | BERMAN, JASON | 1794 | §102 | Non-Final OA | — | Pending | Nov 08, 2023 |
| 18387165 | METHOD FOR INDUCING HYPERTROPHIC MUSCLE FIBERS FOR INDUSTRIAL MEAT PRODUCTION | TAKENAKA, RISA | 1632 | §103 | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18557941 | Biomarkers for Neurodegenerative Disease | COUNTS, GARY W | 1678 | §101 | Final Rejection | 13d | Pending | Oct 29, 2023 |
| 18489882 | STIRRING-FREE SCALABLE ELECTROSYNTHESIS ENABLED BY ALTERNATING CURRENT | WILKINS III, HARRY D | 1794 | §103 | Final Rejection | 46d | Pending | Oct 19, 2023 |
| 18281341 | ACYL ACTIVATING ENZYME AND A TRANSGENIC CELL, TISSUE, AND ORGANISM COMPRISING SAME | SPEED, DEQUANTARIUS JAVON | 1663 | §101§103§112 | Non-Final OA | 117d overdue | Pending | Sep 11, 2023 |
| 18234902 | GENETICALLY MODIFIED BACTERIA FOR GENERATING VACCINES | DUFFY, PATRICIA ANN | 1645 | §102§103§112 | Non-Final OA | — | Pending | Aug 17, 2023 |
| 18262732 | A NONCOVALENT HYBRID COMPRISING CARBON NANOTUBES (CNT) AND AROMATIC COMPOUNDS AND USES THEREOF | RUMMEL, JULIA L | 1784 | §103 | Final Rejection | 36d overdue | Pending | Jul 25, 2023 |
| 18224345 | NON-PROTEIN PHENYLALANINE ANALOGUES FOR INHIBITING CYANOBACTERIA AND PLANT GROWTH | LIU, SUE XU | 1616 | §103§112 | Final Rejection | 168d overdue | Pending | Jul 20, 2023 |
| 18258812 | METHACRYLAMIDES PROTEIN BINDERS AND USES THEREOF | WILLIS, DOUGLAS M | 1624 | §112 | Non-Final OA | — | Pending | Jun 22, 2023 |
| 18334909 | COMPOSITIONS FOR USE IN THE TREATMENT OF CHD2 HAPLOINSUFFICIENCY AND METHODS OF IDENTIFYING SAME | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103DP | Non-Final OA | — | Pending | Jun 14, 2023 |
| 18140095 | AGENTS BINDING MODIFIED ANTIGEN PRESENTED PEPTIDES AND USE OF SAME | BEVERIDGE, CONNOR HAMMOND | — | §103 | Non-Final OA | — | Pending | Apr 27, 2023 |
| 18137455 | METHODS FOR DIFFERENTIATING AND PURIFYING PANCREATIC ENDOCRINE CELLS | GRABER, JAMES J | 1631 | §112 | Non-Final OA | — | Pending | Apr 21, 2023 |
| 18107573 | MAGE-A1 SPECIFIC T CELL RECEPTOR AND USES THEREOF | DUNN, LINDSAY MICHELLE | 1644 | §112 | Non-Final OA | — | Pending | Feb 09, 2023 |
| 17999934 | QUANTUM SIMULATION WITH TRAPPED IONS IN A GRADIENT FIELD | SHALABY, AHMAD HUSSAM | 2187 | §103 | Final Rejection | 5d overdue | Pending | Nov 28, 2022 |
| 18048873 | SYSTEM AND METHOD FOR ULTRASOUND ANALYSIS | CELESTINE, NYROBI I | 3798 | §103 | Non-Final OA | 2d overdue | Pending | Oct 24, 2022 |
| 17958516 | METHODS OF DIAGNOSING CANCER AND PREDICTING RESPONSIVENESS TO THERAPY | SWITZER, JULIET CAROLINE | 1682 | §101§102§103§112 | Non-Final OA | 72d | Pending | Oct 03, 2022 |
| 17915500 | VARIANTS OF BETA-GLUCOCEREBROSIDASE FOR USE IN TREATING GAUCHER DISEASE | XU, QING | 1656 | §112 | Final Rejection | 15d | Pending | Sep 29, 2022 |
| 17884594 | METHOD FOR ANALYZING CELL CLUSTERS | BUNKER, AMY M | 1684 | §102 | Final Rejection | — | Pending | Aug 10, 2022 |
| 17870876 | MULTISPECIFIC ANTIBODIES FOR USE IN TREATING DISEASES | LUNDE, GRACE HENRY | 1641 | §103§112DP | Final Rejection | — | Pending | Jul 22, 2022 |
| 17794268 | ARTICLES OF MANUFACTURE COMPRISING ANTI PD-L1 ANTIBODIES AND THEIR USE IN THERAPY | DRISCOLL, MAUREEN VARINA | 1644 | §103§112 | Non-Final OA | — | Pending | Jul 21, 2022 |
| 17839667 | MICROFLUIDIC DEVICE FOR ANALYZING GENE EXPRESSION | MARVICH, MARIA | 1634 | §112 | Final Rejection | — | Pending | Jun 14, 2022 |
| 17779704 | CHIMERIC ANTIGEN RECEPTOR TO CARBOHYDRATE ANTIGENS | DONOGHUE, BRITTNEY ERIN | 1675 | §112DP | Final Rejection | — | Pending | May 25, 2022 |
| 17637098 | SCALED-UP METHODS FOR PURIFYING ANTIBODIES | IVICH, FERNANDO NMN | 1678 | §102§103§112DP | Non-Final OA | 44d overdue | Pending | Feb 22, 2022 |
| 17614563 | ARTIFICIAL RECEPTORS, RECOMBINANT CELLS COMPRISING THEREOF, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF | IVICH, FERNANDO NMN | 1678 | §103§112Other | Final Rejection | 168d overdue | Pending | Nov 29, 2021 |
| 17515591 | COMPOSITIONS COMPRISING THE PROPEPTIDE OF LYSYL OXIDASE AND USES THEREOF | ALFANO, ALAN | 1600 | §103 | Final Rejection | — | Pending | Nov 01, 2021 |
| 17267816 | DESIGNED, EFFICIENT AND BROAD-SPECIFICITY ORGANOPHOSPHATE HYDROLASES | JONES-FOSTER, ERICA NICOLE | 1656 | §103 | Non-Final OA | — | Pending | Feb 11, 2021 |
| 16885331 | CONDITIONING PROTOCOLS AND USE OF SAME FOR TISSUE REGENERATION | MARTIN, PAUL C | 1653 | §103§112 | Non-Final OA | — | Pending | May 28, 2020 |
| 16331863 | THERMOSTABLE VARIANTS OF P. FALCIPARUM PFRH5 WHICH CAN BE PRODUCED IN BACTERIAL CELLS | ZEMAN, ROBERT A | 1645 | §112 | Final Rejection | — | Pending | Mar 08, 2019 |
| 15516407 | LIPOSOMES-CONTAINING ANTIFOULING COMPOSITIONS AND USES THEREOF | WESTERBERG, NISSA M | 1618 | §103§112Other | Non-Final OA | 87d overdue | Pending | Apr 02, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial